Biohaven’s Nurtec fails to obtain FDA approval for ALS

Date:2019-07-24 Views:394

Biohaven Pharmaceutical has failed to receive the US Food and Drug Administration (FDA) approval for Nurtec (riluzole).

[ Search ] [ ] [ Email ] [ Print ] [ Close ] [ Top ]

Recomment

Popular

Tel:+86-10-68645975 Fax:+86-10-68645973
E-mail:yaoshang68@163.com QQ:1483838028

• SunSirs: On February 19th, the Price of Impo	• SunSirs: Costs Rose and Supply Increased, DO
• SunSirs: After the Holiday, Plasticizer Manu	• SunSirs: Costs Rose, Supply Increased, and D
• SunSirs: Poor Replenishment, the Price of Al	• SunSirs: On February 18th, the Domestic DBP
• SunSirs: The Price of Tetrachloroethylene Ha	• SunSirs: Demand Was Weak, Production Was Res
• SunSirs: Demand Was Weak, Production Was Res	• SunSirs: China Fuel Oil 180CST Market in 202
• SunSirs: The Demand Varies, China Gasoline h	• SunSirs: Just Entering February, the Dimethy
• SunSirs: The Market Price of Lithium Hydroxi	• SunSirs: The Price of Nitric Acid Had Droppe
• SunSirs : The Cement Market Prices in Hunan	• SunSirs: As the New Year Approaching, the Tr
• SunSirs: The Domestic First-class Titanium S	• SunSirs: The Market Price of Ferrous Lithium
• SunSirs: The Price of Sodium Metabisulfite W	• SunSirs: China Domestic Ship Fuel Market Flu
• SunSirs: The Lithium Hydroxide Market in Jan	• SunSirs: The NMP Market Weakly Declined in J
• SunSirs: Summary of Domestic Cobalt Market T	• SunSirs: On January 18th, Prices of Some Dom
• SunSirs: The Potassium Carbonate Market Has	• SunSirs: The Release of Demand Side Was Slow
• SunSirs: The Seamless Tube Market Had Been O	• SunSirs: Sales Were Sluggish, Propane Contin
• SunSirs: Production and Sales are Weak, Chin	• SunSirs: Weak consolidation of China MTBE ma